Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet Glycoprotein IIb/IIIa Inhibitors

Autor: Hitinder S. Gurm, Emily Perdoncin, Min Zhang, Thomas LaLonde, Cindy L. Grines, Arthur Riba

Publikováno v: Circulation: Cardiovascular Interventions. 6:688-693

Background— Use of bivalirudin has been associated with a reduction in the incidence of bleeding in patients undergoing percutaneous coronary intervention. Patients with chronic kidney disease, a known predictor of post–percutaneous coronary inte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95e567a99ca7b89aab135a45bd73987e
https://doi.org/10.1161/circinterventions.113.000554

Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction

Autor: Charles Shoultz, Henri Marais, Ellis Lader, Dhiraj Narula, Cezar Staniloae, Sam Durr, Kevin Marzo, Robert Mendelson, Bilal Malik, Suneet Mittal, Samir Saba, T. Jared Bunch, Rajul Patel, Leng Jiang, Shujahat Shah, Daniel C. Lee, Roopinder K. Sandhu, Steven Hsu, W. Kevin Tsai, Walid Saliba, Preetham Jetty, Kevin H. Silver, Frank Gredler, Zakir Sahul, James Bengston, Mark Niebauer, Neal A. Chatterjee, David B. Delurgio, Daniel G. Anderson, Scott E. Mattson, Greg C. Flaker, Daniel S. Menees, Elizabeth S Kaufman, Susan Graham, Chris Geohas, John F. Heitner, Joel Reinoehl, Otto Costantini, Pedro Colon-Hernandez, Frank McGrew, Brent McLaurin, Arthur Riba, Andre Gauri, Sung Lee, Zayd Eldadah, Nancy R. Cook, William Bugni, Gerald M. Pohost, Matthew Koshy, David E. Haines, Peter Ott, Romel Figueredo, Shelley R. Hankins, Alan H. Kadish, Christopher K. Dyke, Syed M. Mohiuddin, Kathryn Rohr, David Huneycutt, David Kraus, Marcus Averbach, Lindsey L. White, Peter Hotvedt, John McKenzie, David Sandler, Ronald Blonder, Mahmoud Atieh, Norman Erenrich, Sei Iwai, Aziz Hany, Ned Claxton, Hal Skopicki, Steven Klein, Geariod O'Neill, Sorin Danciu, Julie Pester, Diego Sadler, Robert Phang, Jay Schmidt, Udho Thadani, Azhar Aslam, M. Vinayaga Moorthy, Harischandra Karunaratne, James Baker, Jeffrey J. Goldberger, Sean Whalen, Michael Radin, Raul Garcia-Rinaldi, Ronald D. Berger, Michelle Ratliff, Steven D. Owens, Miguel Valderrábano, Christine M. Elbert, Steven Greenberg, Enrique Flores, Pablo Saavedra, Vincent See, David S. Rosenbaum, Michael Fong, Gopi Krishna Panicker, Steven Tishler, Joon Ahn, Mehmet K. Aktas, John E.A. Griffin, Edward Mostel, Stephen Hustead, Charles B. Treasure, Thomas Oliver, Terrence Hack, Talal Baki, Alexander Altschuller, Sharan Mahal, Michael Langer, Benjamin Trichon, Nadim Nasir, Juan M. Aranda, Mohit Bhasin, Patrick Simpson, David Bello, Selcuk Adabag, Kodangudi Ramanathan, Glover Johnson, William Wickemeyer, Charles Gottlieb, Jamal Islam, John Herre, David Wolinsky, Kevin Cochran, Lee Arcement, Judith A. Mackall, Gervasio Lamas, Jeffrey Shanes, Terence Ross, Mirza Baig, Joseph McGarvey, Stephanie H. Dunlap, Robert Weiss, Victoria Bernstein, Terrence X. O'Brien, Mark Myers, Benjamin Cheong, David Serfas, Robert Spencer, William Whang, Charles Gornick, Hemal M. Nayak, Andi Schaecter, J. Thomas Svinarich, Muqtada Chaudhry, P. Kasi Ramanathan, John Kazmierski, John Sobolski, Robert W Biederman, Andrew Sumner, Eve Gillespie, Christine M. Albert, Matthew Nora, Claudio Schuger

Publikováno v: JAMA Cardiology. 3:591

Importance The majority of sudden and/or arrhythmic deaths (SAD) in patients with coronary heart disease occur in those without severe systolic dysfunction, for whom strategies for sudden death prevention are lacking. Objective To provide contemporar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614e50127a2172686101f3bc6000cae6
https://doi.org/10.1001/jamacardio.2018.1049

The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium

Autor: Hitinder S. Gurm, Milan Seth, Simon R. Dixon, Akshay Khandelwal, Emily Perdoncin, David Wohns, Shukri David, Arthur Riba, Louis Cannon

Publikováno v: European heart journal. 37(24)

Aim The purpose of our study was to evaluate the relative impact of bivalirudin on bleeding outcomes associated with trans-radial interventions (TRI) in real world practice. Methods and results Data for patients undergoing percutaneous coronary inter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997a79b0f2c0fbb4e89e551f19d01fbc
https://pubmed.ncbi.nlm.nih.gov/26377400

Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention

Autor: Kirit Patel, Dean E. Smith, David Share, John G. McGinnity, Arthur Riba, Eva Kline-Rogers, Anthony C. DeFranco, Richard McNamara, Michael O'Donnell, Sanjaya Khanal, Cecelia K. Montoye, Mauro Moscucci, Ronald McKechnie, William L. Meengs

Publikováno v: Circulation. 110:271-277

Background— Although prior studies have shown a relationship between anemia and in-hospital mortality after coronary artery bypass grafting and acute myocardial infarction (MI), the prognostic implication of anemia in patients undergoing percutaneo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b72f380900fa078dd49b8970d01c069
https://doi.org/10.1161/01.cir.0000134964.01697.c7

Trends in Door-to-Balloon Time and Mortality in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Autor: Arthur Riba, Dean G. Smith, Hameem Changezi, Mauro Moscucci, Hitinder S. Gurm, David Share, Thomas LaLonde, Anneliese Flynn

Publikováno v: Archives of Internal Medicine. 170

In patients with acute ST-elevation myocardial infarction (STEMI) who are undergoing percutaneous coronary intervention, current guidelines for reperfusion therapy recommend a door-to-balloon (DTB) time of less than 90 minutes. Considerable effort ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc30725d3c6f11b58050b03aad2bba6
https://doi.org/10.1001/archinternmed.2010.381